Director Shareholding – 26 March 2009
26 March 2009 – The Board of Craneware plc, (AIM: CRW.L), a leader in financial improvement software solutions for the US healthcare market, was informed on 26 March 2009 that on the same day Mr. Neil Heywood, Non-executive director of Craneware, bought 4,488 ordinary shares of 1 pence each in the Company (“Ordinary Shares”) at a price of 225 pence per share, plus an additional 2,232 Ordinary Shares at a price of 224 pence per share.
Following these transactions, Mr. Heywood is interested in a total of 145,272 Ordinary Shares, representing approximately 0.58% of the Company’s issued share capital of 25,152,850 Ordinary Shares.
For further information, please contact:
- +44 (0) 131 550 3100
- Keith Neilson, CEO
- Craig Preston, CFO
- +44 (0) 20 7418 8900
- Oliver Scott
- Nicholas Marren
- +44 (0) 20 7653 9850
- Caroline Evans-Jones
- Fiona Conroy
Founded in 1999, Craneware has headquarters in Edinburgh, Scotland with offices in Atlanta, Arizona, Massachusetts and Tennessee employing over 200 staff. Craneware is the leader in automated revenue integrity solutions that improve financial performance and mitigate risk for healthcare organisations. Craneware’s market-driven, SaaS solutions help hospitals and other healthcare providers more effectively price, charge and code for services and supplies associated with patient care. These optimise reimbursement, increase operational efficiency and minimise compliance risk. By partnering with Craneware, clients achieve the visibility required to identify, address and prevent revenue leakage. To learn more, visit craneware.com.
You might also like...
Dec 21, 2018 | Announcements
Strong performance expected to deliver revenue and adjusted EBITDA growth in the range of 15% to 20% 21 December 2018 - Craneware (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, notes the recent...read more
Nov 9, 2018 | Announcements
09 November 2018 - Craneware plc (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, today gives further information regarding its final dividend announced on 4 September 2018. For those shareholders...read more